4.5 Article

Expression of the Active Notch1 Decreases MTC Tumor Growth In Vivo

Journal

JOURNAL OF SURGICAL RESEARCH
Volume 171, Issue 1, Pages 23-27

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jss.2011.03.035

Keywords

Notch1 pathway; tumor suppressor; medullary thyroid cancer (MTC); chromogranin A; achaete-scute complex-like 1; xenograft model

Categories

Funding

  1. National Institutes of Health [CA109053, CA121115]
  2. National Cancer Institute [P30 CA014520]

Ask authors/readers for more resources

Background. Human medullary thyroid cancer (MTC) is a neuroendocrine (NE) tumor, derived from thyroid C-cells. Besides surgery, there are no curative therapies for MTC. This emphasizes the need for the development of new therapies. In MTC, Notch1 signaling pathway is absent and Notch1 activation in MTC-TT cells has been shown to reduce growth and NE markers in vitro. While the in vitro studies will provide insight into the potential mechanisms by which Notch inhibits growth, only by in vivo model one can recreate the conditions found in patients with MTC and assess effects on metastatic potential and microscopic disease. Materials and Methods. Doxycycline inducible TT-NOTCH1 cells were utilized in a murine subcutaneous xenograft model to study tumor development and growth. Doxycycline was used to induce the expression of Notch1 in these tumors. Results. Measurements of tumor volume showed that doxycycline treated mice had slower tumor growth than control mice. Western blot analysis of tumor lysates demonstrated activation of Notch1 protein only in doxycycline treated mice suggesting that active Notch1 slowed tumor growth. Furthermore, this activation led to a significant reduction in the levels of achaete-scute complex-like1 and chromogranin A important NE markers. Conclusion. Based on these data, activation of Notch signaling pathway could be a therapeutic strategy to treat patients with MTC. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available